Meet our Speakers
We've gathered some of the top experts in the field to discuss this topic. With years of experience between them, they're well-equipped to offer invaluable insights and perspectives.
Prof. Rushika Perera
Arthropod-borne & Infectious Diseases Laboratory Colorado State University, USA
Prof. A. Ozlem Tastan Bishop
Department of Biochemistry and Microbiology, Rhodes University, South Africa
Dr Jeremy W Prokop
Department of Pharmacology & Toxicology, Michigan State University, Grand Rapids, USA
Talks
Baricitinib as a potential drug for COVID-19: evidence from a multicenter trial and translational research studies
Allosteric site of SARS-CoV-2 main protease as drug target in the presence of its emerging mutations
Bioengineering tools to speed up the discovery and preclinical testing of vaccines for SARS-CoV-2 and therapeutic agents for COVID-19
Internet Knowledge Mining tools and A.I. For Rapid Response to New Pandemics with Proposals for Synthetic Vaccines and Therapeutics. The Example of COVID19
Screening Possible Drug Molecules for Covid-19: A Computational Study based on Docking Studies & Molecular Dynamics to Design New Inhibitor Candidates
In silico drug discovery for COVID-19 using gene expression profiles of mouse infected by MHV and those of human cell lines infected by SARS-CoV-2
Machine learning analysis of single-cell gene regulatory networks reveals potential mechanisms of action of antimalarials against SARS-CoV-2
The Clinically Validated Viral Superinfection Therapy (SIT) Platform Technology May Mitigate Severe Cases of COVID-19 Infections
